Table 1. Demographics of 114 CHB patients.
| HCC (n = 57) | Non-HCC (n = 57) | p value | |
|---|---|---|---|
| Age#, years | 61.4 (55.9–62.0) | 61.1 (56.9–66.3) | 0.764 |
| Male#, n (%) | 48 (84.2%) | 48 (84.2%) | n.a. |
| HBeAg-negative#, n (%) | 56 (98.2%) | 56 (98.2%) | n.a. |
| Cirrhosis#, n (%) | 34 (59.6%) | 34 (59.6%) | n.a. |
| Albumin, g/L | 44 (41–46) | 44 (42–46) | 0.813 |
| Bilirubin, umol/L | 12 (8–15) | 11 (8–17) | 0.370 |
| ALT, U/L | 29 (20–38) | 23 (20–28) | 0.009 |
| Platelet, x 10 ^9/L | 163 (115–203) | 168 (137–215) | 0.151 |
| INR | 1.1 (1–1.1) | 1.1 (1–1.1) | 0.865 |
| AFP, ng/mL | 11 (5–32) | 3 (2–4) | < 0.001 |
| Undetectable DNA#, n (%) | 57 (100%) | 57 (100%) | n.a. |
| Duration of therapy#, years | 3.2 (2.0–5.0) | 3.6 (2.2–5.1) | 0.626 |
Continuous variables expressed as median (interquartile range).
CHB, chronic hepatitis B virus; HCC, hepatocellular carcinoma; ALT, alanine aminotransferase; INR, international normalised ratio; AFP, alpha-fetal protein.
#Matched variables.
n.a., p-value not applicable as these were matched categorical variables.